Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

Wu-Tong Ju; Ying Liu; Li-Zhen Wang; Jiang Li; Guo-Xing Ren; Jian Sun; Wen-Yong Tu; Yong-Jie Hu; Tong Ji; Wen-Jun Yang; Jun Li; Yue He; Yan-An Wang; Chen-Ping Zhang; Lai-Ping Zhong; Zhi-Yuan Zhang

doi:10.1002/cac2.12136

Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

Cancer Commun (Lond). 2021 Mar;41(3):279-283. doi: 10.1002/cac2.12136. Epub 2021 Jan 20.

Authors

Wu-Tong Ju^{1

2}, Ying Liu^{1

2}, Li-Zhen Wang³, Jiang Li³, Guo-Xing Ren^{1

2}, Jian Sun^{1

2}, Wen-Yong Tu^{1

2}, Yong-Jie Hu^{1

2}, Tong Ji^{1

2}, Wen-Jun Yang^{1

2}, Jun Li^{1

2}, Yue He^{1

2}, Yan-An Wang^{1

2}, Chen-Ping Zhang^{1

2}, Lai-Ping Zhong^{1

2}, Zhi-Yuan Zhang^{1

2}

Affiliations

¹ Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.
² National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, 200011, P. R. China.
³ Department of Oral Pathology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.

No abstract available

Publication types

Clinical Trial, Phase III
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biomarkers
Cisplatin*
Docetaxel / therapeutic use
Fluorouracil
Humans
Induction Chemotherapy
Mouth Neoplasms* / drug therapy
Treatment Outcome

Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

Authors

Affiliations

Publication types

MeSH terms

Substances

Associated data

Grants and funding